Dexmedetomidine and the successful management of electroconvulsive therapy postictal agitation: A case report

Elizabeth M. O'brien; Peter B. Rosenquist; James N. Kimball; Gregory N. Dunn; Bryan Smith; Lorraine M. Arias

doi:10.1097/YCT.0b013e3181b07c26

Dexmedetomidine and the successful management of electroconvulsive therapy postictal agitation: A case report

Elizabeth M. O'brien, Peter B. Rosenquist, James N. Kimball, Gregory N. Dunn, Bryan Smith, Lorraine M. Arias

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Abstract

Postictal agitation after electroconvulsive therapy is a common and serious condition and when severe, requires prompt intervention to safeguard the patient and medical staff from the potential for mayhem and physical harm. We present a case report on the successful use of dexmedetomidine, an α2 agonist, in the postictal management of severe agitation in a 34-year-old morbidly obese woman, after prior modes of intervention had failed to deliver ideal conditions.

Original language	English (US)
Pages (from-to)	131-133
Number of pages	3
Journal	Journal of ECT
Volume	26
Issue number	2
DOIs	https://doi.org/10.1097/YCT.0b013e3181b07c26
State	Published - Jun 2010
Externally published	Yes

Keywords

Dexmedetomidine
ECT
Morbid obesity
Postictal agitation
Sedation
α2 agonist

ASJC Scopus subject areas

Neuroscience (miscellaneous)
Psychiatry and Mental health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/YCT.0b013e3181b07c26

Cite this

@article{de03caa35692464c86345a7e7a8a1b07,

title = "Dexmedetomidine and the successful management of electroconvulsive therapy postictal agitation: A case report",

abstract = "Postictal agitation after electroconvulsive therapy is a common and serious condition and when severe, requires prompt intervention to safeguard the patient and medical staff from the potential for mayhem and physical harm. We present a case report on the successful use of dexmedetomidine, an α2 agonist, in the postictal management of severe agitation in a 34-year-old morbidly obese woman, after prior modes of intervention had failed to deliver ideal conditions.",

keywords = "Dexmedetomidine, ECT, Morbid obesity, Postictal agitation, Sedation, α2 agonist",

author = "O'brien, {Elizabeth M.} and Rosenquist, {Peter B.} and Kimball, {James N.} and Dunn, {Gregory N.} and Bryan Smith and Arias, {Lorraine M.}",

year = "2010",

month = jun,

doi = "10.1097/YCT.0b013e3181b07c26",

language = "English (US)",

volume = "26",

pages = "131--133",

journal = "Journal of ECT",

issn = "1095-0680",

publisher = "Lippincott Williams and Wilkins",

number = "2",

}

TY - JOUR

T1 - Dexmedetomidine and the successful management of electroconvulsive therapy postictal agitation

T2 - A case report

AU - O'brien, Elizabeth M.

AU - Rosenquist, Peter B.

AU - Kimball, James N.

AU - Dunn, Gregory N.

AU - Smith, Bryan

AU - Arias, Lorraine M.

PY - 2010/6

Y1 - 2010/6

N2 - Postictal agitation after electroconvulsive therapy is a common and serious condition and when severe, requires prompt intervention to safeguard the patient and medical staff from the potential for mayhem and physical harm. We present a case report on the successful use of dexmedetomidine, an α2 agonist, in the postictal management of severe agitation in a 34-year-old morbidly obese woman, after prior modes of intervention had failed to deliver ideal conditions.

AB - Postictal agitation after electroconvulsive therapy is a common and serious condition and when severe, requires prompt intervention to safeguard the patient and medical staff from the potential for mayhem and physical harm. We present a case report on the successful use of dexmedetomidine, an α2 agonist, in the postictal management of severe agitation in a 34-year-old morbidly obese woman, after prior modes of intervention had failed to deliver ideal conditions.

KW - Dexmedetomidine

KW - ECT

KW - Morbid obesity

KW - Postictal agitation

KW - Sedation

KW - α2 agonist

UR - http://www.scopus.com/inward/record.url?scp=77953153587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953153587&partnerID=8YFLogxK

U2 - 10.1097/YCT.0b013e3181b07c26

DO - 10.1097/YCT.0b013e3181b07c26

M3 - Article

C2 - 19710618

AN - SCOPUS:77953153587

SN - 1095-0680

VL - 26

SP - 131

EP - 133

JO - Journal of ECT

JF - Journal of ECT

IS - 2

ER -

Dexmedetomidine and the successful management of electroconvulsive therapy postictal agitation: A case report

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this